COVID-19 Project Selection
Committee
Doug Buchanan
Committee CHair | M.Sc. , MBA,
For more than twenty years, Doug Buchanan was the Managing Director & CEO of BC Biomedical Laboratories Ltd. He provided leadership to all functional areas of the practice and led significant changes in the organization, including several acquisitions, and the development of a new, leading-edge laboratory. Read more
Dr. Catalina Lopez-Correa
COO at Ruta N Medellin
With more than 20 years of international experience in both the academic and private sectors, Dr. Catalina Lopez-Correa’s deep understanding of genomics and innovation has inspired leaders in science and industry to collaborate toward solving some of the world’s greatest challenges. Read more
Tara McCarville
Principal, Brighton Group
Tara McCarville is a Principal Consultant at Brighton Group, a health industries solutions firm. As the former National Health Industries Leader for PwC Canada, Tara was accountable for leading a national practice focused on improving quality and outcomes for government, hospital, healthtech/medtech, home/long term care, and private equity clients. Read more
Alan E Winter
PhD, FCAE
Alan Winter was British Columbia’s first Innovation Commissioner from 2018-2020. He has wide experience at senior levels in the technology sector and in government. Dr Winter has been a director of over 30 organizations and companies. Read more
Sally Daub
Founder & Managing Partner, Pool Global Partners
Sally Daub is a technology entrepreneur, venture capitalist and CEO with experience in semiconductors, consumer electronics, healthcare, quantum computing and blockchain. As Founder and Managing Partner of Pool Global Partners, Sally is investing in the next generation of deep-tech innovation and supporting founders by sharing her expertise. Read more
Dr. Geoff Houlton
Mentor| Consultant | Advisor
Dr Houlton qualified in medicine from Ninewells Medical School at the University of Dundee. Following residency training in anesthesiology he joined the pharmaceutical industry in the UK as a medical advisor in product development. He was recruited to Canada to lead the development of the Medical Affairs Department of Glaxo Canada Inc. now Glaxo SmithKline (GSK). Read more